At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Medtronic DBS systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
OPTIVISE Map Concordance Study in DBS for Parkinson's Disease
In Brief
An observational study evaluating Medtronic DBS system for Parkinson's Disease. Completed, enrolled 20 participants across 2 sites.
Detailed Summary
To evaluate DBS device settings and match with the features of the DBS care management software.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson's Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2012
First PostedDec 2012
Primary CompletionMay 2013
Study CompletionAug 2013
TodayJul 2026
First PostedDec 17, 2012
Enrollment StartNov 1, 2012
Primary CompletionMay 1, 2013
Study CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 13.5 years ago
Interventions
Medtronic DBS systemdevice
Advanced Parkinson's disease patients implanted with the Medtronic Deep Brain Stimulation (DBS) system.